**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 5579-84-0 |2-Pyridineethanamine, N-methyl-, dihyd| 99 | 226-966-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Use with adequate ventilation. Avoid breathing dust.
Storage:
Keep container closed when not in use. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 5579-84-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: faint yellow
Odor: Not available.
pH: 2-4 (2% soln)
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 148-154 deg C
Autoignition Temperature: Not available.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density:
Molecular Formula: C8H12N2.2HCl
Molecular Weight: 209.12
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 5579-84-0: UT2969000
LD50/LC50:
Not available.
Human oral TDLo 108 mg/kg/12W intermittent: general depressed
activity and diarrhea.
Carcinogenicity:
2-Pyridineethanamine, N-methyl-, dihydrochloride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 5579-84-0: No information available.
Canada
CAS# 5579-84-0 is listed on Canada's DSL List.
CAS# 5579-84-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5579-84-0 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/25/1999 Revision #3 Date: 4/02/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Alpha, Alpha, Alpha-Trifluoro-P-Tolunitrile, 99%
| 455-18-5 |
|
Ethyl 4-methoxybenzoate, 98%
| 94-30-4 |
|
Ethanesulfonic Acid, 95% (Titr.)
| 594-45-6 |
|
3,6-Dihydroxybenzonorbornane, 96% (uv-vis)
| 15155-91-5 |
|
Ethyl 3-Aminobenzoate, 99+%
| 582-33-2 |
|
Chromium(III)acetylacetonate, 97%
| 21679-31-2 |
|
2-(2-(Methylamino)ethyl)pyridine dihydrochloride
| 5579-84-0 |
|
2-Amino-4-chlorobenzoic acid, 98%
| 89-77-0 |
|
N-(2-Hydroxyethyl)Pyrrolidine, 95%
| 2955-88-6 |
|
2,2,2-Trifluoroethyl P-Toluenesulfonate 98%
| 433-06-7 |
|
3,4-Diethoxybenzoic Acid, 99%
| 5409-31-4 |
|
1-Octadecanol 95%
| 112-92-5 |
|
DL-2,3-Diaminopropionic Acid Monohydrochloride, 99%
| 54897-59-5 |
|
5-Methyl-3-heptanone, 96% (gc)
| 541-85-5 |
|
1-Bromo-2,2-dimethoxypropane, 97%
| 126-38-5 |
|
Phenyl 4-Aminosalicylate, 99%
| 133-11-9 |
|
Tetraethyltin, 97%
| 597-64-8 |
|
1-Piperazinepropanol, 98%
| 5317-32-8 |
|
Diethyl Methylmalonate, 99%
| 609-08-5 |
|
2,2,6,6-Tetramethylcyclohexanone, 98%
| 1195-93-3 |
|
2-Nitroresorcinol
| 601-89-8 |
|
o-Methoxycinnamic acid, predominantly trans
| 6099-03-2 |
|
4-Aminobenzyl cyanide, 99%
| 3544-25-0 |
|
2,3-Dichloropyridine, 99%
| 2402-77-9 |
|
2-Amino-1-Phenylethanol, 98%
| 7568-93-6 |
|
Dipropylene Glycol, Tech., 99% (GC) Mixture of Isomeric Propylene
| 25265-71-8 |
|
Dibenzylamine, 98%
| 103-49-1 |
|
6-Chloro-2-picoline, 98%
| 18368-63-3 |
|
Diethyl Oxalacetate Sodium Salt (PRACT)
| 40876-98-0 |
|
Cyclobutanecarboxylic Acid, 98%
| 3721-95-7 |
|
2-(2-Ethoxyethoxy)ethyl Acetate, 99%
| 112-15-2 |
|
2-Mercapto-6-Nitrobenzothiazole, 96% (Titr.)
| 4845-58-3 |
|
Dihydrocytochalasin B
| 39156-67-7 |
|
3-Chloropropylamine Hydrochloride, 98%
| 6276-54-6 |
|
2-Amino-3-Methylbenzoic Acid, 98%
| 4389-45-1 |
|
m-Phenetidine, 96% (gc)
| 621-33-0 |
|
4,4-Diphenylsemicarbazide, 98%
| 603-51-0 |
|
3-Methyl-1-pentyn-3-ol, 99+%
| 77-75-8 |
|
(R)-(+)-N-Benzyl-alpha-methylbenzylamine, 98%
| 38235-77-7 |
|
1,7-Diaza-15-Crown-5, 99%
| 31249-95-3 |
|
l-(-)-Xylose, p.a.
| 609-06-3 |
|
4-Hydroxybenzylidenemalonodinitrile, 99%
| 3785-90-8 |
|
2,2'-Dithiodipyridine, 98%
| 2127-03-9 |
|
Mercury atomic absorption standard solution, 1 mg/ml Hg in 10% HNO3
| 7439-97-6 |
|
Lissamine Rhodamine B Sulfonyl Chloride, 99+% (UV-VIS)
| 62796-29-6 |
|
2,4-Diethyl-2,6-heptadienal, 97% Mixture of Isomers
| 85136-07-8 |
|
Dimethyldiselenide, 99+%
| 7101-31-7 |
|
2-Amino-4-Hydroxy-1H-Pteridine
| 2236-60-4 |
|
Alpha-Bromo-O-Tolunitrile, 98%
| 22115-41-9 |
|
(2-Chloroethyl)trimethylammonium chloride, 98%
| 999-81-5 |
|
|